0 Bedömningar
ID

34272

Beskrivning

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets; ODM derived from: https://clinicaltrials.gov/show/NCT01510522

Länk

https://clinicaltrials.gov/show/NCT01510522

Nyckelord

Versioner (2)
  1. 2019-01-16 2019-01-16 -
  2. 2019-05-14 2019-05-14 -
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

16 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    Engelsk

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    1 Formulär  
    Inclusion Criteria
    Beskrivning

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
    Beskrivning

    ID.1

    Datatyp

    boolean

    on treatment with metformin tablets
    Beskrivning

    ID.2

    Datatyp

    boolean

    patients with at least 2 treated co-morbidities
    Beskrivning

    ID.3

    Datatyp

    boolean

    established dose of metformin > 1.700 mg/day
    Beskrivning

    ID.4

    Datatyp

    boolean

    age > 18 years old
    Beskrivning

    ID.5

    Datatyp

    boolean

    given informed consent
    Beskrivning

    ID.6

    Datatyp

    boolean

    Exclusion Criteria
    Beskrivning

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    patients not able to take medication orally
    Beskrivning

    ID.7

    Datatyp

    boolean

    according to summary of product characteristics (smpc)
    Beskrivning

    ID.8

    Datatyp

    boolean

    participating in another clinical trial 30 days prior to randomization
    Beskrivning

    ID.9

    Datatyp

    boolean

    any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
    Beskrivning

    ID.10

    Datatyp

    boolean

    Tillbaka till toppen

    Similar models

    Eligibility Diabetes Mellitus Type 2 NCT01510522

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
    boolean
    ID.2
    Item
    on treatment with metformin tablets
    boolean
    ID.3
    Item
    patients with at least 2 treated co-morbidities
    boolean
    ID.4
    Item
    established dose of metformin > 1.700 mg/day
    boolean
    ID.5
    Item
    age > 18 years old
    boolean
    ID.6
    Item
    given informed consent
    boolean
    Item Group
    C0680251 (UMLS CUI)
    ID.7
    Item
    patients not able to take medication orally
    boolean
    ID.8
    Item
    according to summary of product characteristics (smpc)
    boolean
    ID.9
    Item
    participating in another clinical trial 30 days prior to randomization
    boolean
    ID.10
    Item
    any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
    boolean
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial